LIFECORE BIOMEDICAL INC DE
For the period ended Aug 7, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 7, 2025 · Filed Aug 7, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Operations
Operations
In support of the company’s value creation initiatives, Lifecore has continued to make impactful improvements to operations. Under new leadership who bring significant CDMO experience to Lifecore, the organization identified areas of improvement and implemented changes that reduced operational expenses and improved productivity. Senior management has also established a performance-driven culture and reinforced Lifecore’s commitment to quality. Progress in each of these areas during the fourth quarter and fiscal year resulted in improved operational efficiency and profitability.
The company remains on track to launch a new enterprise resource planning (“ERP”) system, which is planned for the first quarter of 2026. The new system is expected to enable further operational efficiencies and to drive cost savings via a faster timeline to an integrated audit, and an earlier remediation of the company’s control environment.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.